Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast Cancer

8 Nov 2012

Abstract excerpt

INTRODUCTION: Detection of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) in the peripheral blood of patients with solid tumors has been widely studied for the early detection of metastatic spread. We evaluated whether there was an association between the origin of cfDNA and CTCs. We investigated whether SRY (sex determining region Y)-box 17 (SOX17) promoter methylation in CTCs was associated with the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23136251
DOI: 10.1373/clinchem.2012.191551

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SOX17 Promoter Methylation in Circulating Tumor Cells and Matched Cell-Free DNA Isolated from Plasma of Patients with Breast CancerPMID 23136251Read ↗

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancerSemantic proximity Read ↗

Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast CancerSemantic proximity Read ↗

DNA Methylation of Tumor Suppressor and Metastasis Suppressor Genes in Circulating Tumor CellsSemantic proximity Read ↗

SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancerSemantic proximity Read ↗

Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in WomenSemantic proximity Read ↗

Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survivalSemantic proximity Read ↗

Genetic and epigenetic modifications of HPDL and SOX17 associated with breast cancer prognosis: a study based on The Cancer Genome AtlasSemantic proximity Read ↗

Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical OutcomesSemantic proximity Read ↗

Abnormal methylation of the sex-determining region Y-box 17 (SOX17) promoter predicts poor prognosis in myelodysplastic syndrome.Semantic proximity Read ↗

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian CancerSemantic proximity Read ↗

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.Semantic proximity Read ↗

DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detectionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.